Vasomune Therapeutics, Inc.
- Biotech or pharma, therapeutic R&D
Vasomune Therapeutics is a private clinical stage biopharmaceutical company that is developing AV-001, a Tie2 agonist, to activate vascular endothelial stabilization, and block vascular leak.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}